Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elise A Chong

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Blood Advances|June 11, 2024
CAR-T for large B-cell lymphomas: the clock is tickingElise A Chong
Transplantation and Cellular Therapy|December 4, 2024
Immune checkpoint inhibition and CAR T-cells: no longer exhausted?Janna Minehart, Elise A Chong
Hematology. American Society of Hematology. Education Program|December 4, 2020
Immunotherapy with cellsElise A Chong, David L Porter
Blood|April 14, 2022
No CNS sanctuary for lymphoma from CAR TElise A Chong, Stephen J Schuster
The New England Journal of Medicine|February 17, 2021
Five-Year Outcomes for Refractory B-Cell Lymphomas with CAR T-Cell TherapyElise A Chong, Marco Ruella, Stephen J Schuster, et al.
International Journal of Radiation Oncology, Biology, Physics|November 22, 2019
Don't Get Stuck on the Shoulder: Radiation Oncologists Should Get Into the CAR With T-Cell TherapiesJohn P Plastaras, Elise A Chong, Stephen J Schuster
American Journal of Hematology|February 7, 2026
2026 Update on the Management of Diffuse Large B-Cell LymphomaElise A Chong, Emily B Tomasulo, Stefan K Barta
British Journal of Haematology|November 22, 2020
CAR-T TREK through the lymphoma universe, to boldly go where no other therapy has gone beforeGuido Ghilardi, Peter Braendstrup, Elise A Chong, et al.
Clinical Nuclear Medicine|September 23, 2008
Marginal zone lymphoma involving subcutaneous fat: appearance by FDG-PET/CT, MRI, and contrast-enhanced CT imagingElise A Chong, Drew A Torigian, Anthony R Mato, et al.
Leukemia & Lymphoma|March 7, 2024
Stereotactic radiotherapy and CART for treatment of secondary CNS lymphomaWisdom Akingbemi, Goldie Kurtz, Nikhil Yegya-Raman, et al.
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Blood Advances|June 11, 2024
CAR-T for large B-cell lymphomas: the clock is tickingElise A Chong
Transplantation and Cellular Therapy|December 4, 2024
Immune checkpoint inhibition and CAR T-cells: no longer exhausted?Janna Minehart, Elise A Chong
Hematology. American Society of Hematology. Education Program|December 4, 2020
Immunotherapy with cellsElise A Chong, David L Porter
Blood|April 14, 2022
No CNS sanctuary for lymphoma from CAR TElise A Chong, Stephen J Schuster
The New England Journal of Medicine|February 17, 2021
Five-Year Outcomes for Refractory B-Cell Lymphomas with CAR T-Cell TherapyElise A Chong, Marco Ruella, Stephen J Schuster, et al.
International Journal of Radiation Oncology, Biology, Physics|November 22, 2019
Don't Get Stuck on the Shoulder: Radiation Oncologists Should Get Into the CAR With T-Cell TherapiesJohn P Plastaras, Elise A Chong, Stephen J Schuster
American Journal of Hematology|February 7, 2026
2026 Update on the Management of Diffuse Large B-Cell LymphomaElise A Chong, Emily B Tomasulo, Stefan K Barta
British Journal of Haematology|November 22, 2020
CAR-T TREK through the lymphoma universe, to boldly go where no other therapy has gone beforeGuido Ghilardi, Peter Braendstrup, Elise A Chong, et al.
Clinical Nuclear Medicine|September 23, 2008
Marginal zone lymphoma involving subcutaneous fat: appearance by FDG-PET/CT, MRI, and contrast-enhanced CT imagingElise A Chong, Drew A Torigian, Anthony R Mato, et al.
Leukemia & Lymphoma|March 7, 2024
Stereotactic radiotherapy and CART for treatment of secondary CNS lymphomaWisdom Akingbemi, Goldie Kurtz, Nikhil Yegya-Raman, et al.
Pageof 8